Black patients more likely to be excluded from pancreatic cancer

Issue 13 - The Cancer Letter

PDF] Skeletal Muscle Fibrosis in Pancreatic Cancer Patients with Respect to Survival

Risk of Pancreatic Cancer and Use of Dipeptidyl Peptidase 4 Inhibitors in Patients with Type 2 Diabetes: A Propensity Score-Matching Analysis

AACI Update

C-reactive protein/albumin ratio is the most significant inflammatory marker in unresectable pancreatic cancer treated with FOLFIRINOX or gemcitabine plus nab-paclitaxel

Differentiation of chronic mass-forming pancreatitis from pancreatic d

SOM Discoveries 2022 VCU School of Medicine

Black patients in Wisconsin 50% less likely to be treated for pancreatic cancer - School of Medicine and Public Health

Pancreatic Cancer Treatment (PDQ®) - NCI

Bassel El-Rayes named deputy director of O'Neal Comprehensive Cancer Center - The Cancer Letter

PDF] Early detection of pancreatic cancer: why, who, and how to screen.

Meta-analysis on inoperable pancreatic cancer: A comparison between gemcitabine-based combination therapy and gemcitabine alone

Frontiers Prognostic Factors of Survival in Pancreatic Cancer Metastasis to Liver at Different Ages of Diagnosis: A SEER Population-Based Cohort Study

SOM Discoveries 2022 VCU School of Medicine